Novo Nordisk A/S NVO:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 05/03/24 EDT

122.90

-0.15 (-0.12%)

Volume

259,968

123.05

-0.97 (-0.78%)

Volume

5,230,154

52 week range

75.56 - 138.28

Open122.92
Day High123.77
Day Low121.29
Prev Close124.02
52 Week High138.28
52 Week High Date03/07/24
52 Week Low75.56
52 Week Low Date07/11/23

Key Stats

Market Cap554.956B
Shares Out4.51B
10 Day Average Volume4.62M
Dividend1.37
Dividend Yield1.11%
Beta0.42
YTD % Change18.95

KEY STATS

Open122.92
Day High123.77
Day Low121.29
Prev Close124.02
52 Week High138.28
52 Week High Date03/07/24
52 Week Low75.56
52 Week Low Date07/11/23
Market Cap554.956B
Shares Out4.51B
10 Day Average Volume4.62M
Dividend1.37
Dividend Yield1.11%
Beta0.42
YTD % Change18.95

RATIOS/PROFITABILITY

EPS (TTM)2.76
P/E (TTM)44.63
Fwd P/E (NTM)0.79
EBITDA (TTM)15.803B
ROE (TTM)88.07%
Revenue (TTM)33.409B
Gross Margin (TTM)84.60%
Net Margin (TTM)36.03%
Debt To Equity (MRQ)25.34%

EVENTS

Earnings Date08/07/2024(est)
Ex Div Date03/22/2024
Div Amount0.9293
Split Date-
Split Factor-

Latest On Novo Nordisk A/S

Amgen stock soars on weight loss drug progress as Novo Nordisk, Eli Lilly slideMay 3, 2024CNBC.com
Wegovy maker Novo Nordisk extends losses following first-quarter resultsMay 3, 2024CNBC.com
Stocks making the biggest moves premarket: Apple, Amgen, Cloudflare and moreMay 3, 2024CNBC.com
European markets close higher; French banks gain on profit beats as Novo Nordisk slidesMay 3, 2024CNBC.com
Novo Nordisk falls after strong Q1 results, Mizuho's Jared Holz talks what's next for the companyMay 2, 2024CNBC.com

Content From Our Affiliates

Amgen price target raised to $325 from $315 at BofAMay 3, 2024TipRanks
Unusually active option classes on open May 2ndMay 2, 2024TipRanks
Novo Nordisk Q1 Sales and Profit SurgeMay 2, 2024TipRanks
Novo Nordisk reports Q1 EPS DKK 5.68 vs. DKK 4.39 last yearMay 2, 2024TipRanks
Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), Sarepta Therapeutics (SRPT) and Acadia Healthcare (ACHC)May 2, 2024TipRanks

Profile

Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral...

Henrik Poulsen

Vice Chairman of the Board

Helge Lund

Independent Chairman of the Board

Lars Fruergaard Joergensen

President, Chief Executive Officer

Maziar Doustdar

Executive Vice President - International Operations

Karsten Munk Knudsen

Chief Financial Officer, Executive Vice President

Douglas Langa

Executive Vice President, North America Operations

Address

Novo Alle 1

Bagsvaerd

2880

Denmark

https://www.novonordisk.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
CAH Cardinal Health Inc	98.91	-4.07	-3.95%
JNJ Johnson & Johnson	149.27	-0.65	-0.43%
RDY Dr Reddy's Laboratories Ltd	75.21	+0.43	+0.58%
MRK Merck & Co Inc	127.51	-0.75	-0.58%
ABBV AbbVie Inc	163.79	+2.98	+1.85%